(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SPAYVAC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SPAYVAC

ST13

US500000076274564

Class

5

Filing

76274564

Registration

2886949

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

02/04/2025

Trademark type

Word

Nice classes

5

Filing date

06/20/2001

Registration date

09/21/2004

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/10/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

02/14/2000

First use in commerce

01/01/2004

Drawing code

1

Owner type

03

Owner location

MADISON, WI

Examiner

SOUDERS, MICHAEL

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SPAYVAC FOR WILDLIFE, INC.
HIMV LLC
ImmunoVaccine Technologies Inc.
ImmunoVaccine Technologies Inc.

Representatives

JEFFREY A. SMITH MILLEN, WHITE, ZELANO & BRANIGAN P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

VACCINES

Publications

History of USPTO decisions and trademark events.

40 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/10/2025

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

01/10/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/10/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/10/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/02/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

09/23/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/11/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/21/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED

10/14/2014

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/23/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/23/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/23/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/23/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

09/11/2014

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

10/24/2009

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/24/2009

ES8R

TEAS SECTION 8 RECEIVED

10/23/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

09/21/2004

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/20/2004

DOCK

ASSIGNED TO EXAMINER

07/13/2004

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/09/2004

IUAF

USE AMENDMENT FILED

06/23/2004

MAIL

PAPER RECEIVED

06/23/2004

FAXX

FAX RECEIVED

06/14/2004

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

12/23/2003

PUBO

PUBLISHED FOR OPPOSITION

09/30/2003

NPUB

NOTICE OF PUBLICATION

09/10/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/05/2003

CFIT

CASE FILE IN TICRS

07/07/2003

MAIL

PAPER RECEIVED

07/02/2003

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/02/2003

MAIL

PAPER RECEIVED

06/25/2003

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/02/2003

CNSI

INQUIRY AS TO SUSPENSION MAILED

05/01/2003

CNSL

LETTER OF SUSPENSION MAILED

09/23/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/20/2002

MAIL

PAPER RECEIVED

08/20/2002

CNSI

INQUIRY AS TO SUSPENSION MAILED

02/25/2002

CNSL

LETTER OF SUSPENSION MAILED

08/23/2001

DOCK

ASSIGNED TO EXAMINER

08/21/2001

Continuous trademark protection

Get notified about every new filing that threatens SPAYVAC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.